Last reviewed · How we verify
Manganese Chloride In Plastic Container (MANGANESE CHLORIDE)
At a glance
| Generic name | MANGANESE CHLORIDE |
|---|---|
| Sponsor | Pfizer |
| Drug class | manganese chloride |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 1997 |
Approved indications
Common side effects
Key clinical trials
- Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease (PHASE2)
- Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer (PHASE2)
- Effect of Probiotics After Neurosurgery (NA)
- First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent (PHASE1)
- Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection (NA)
- Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function (PHASE3)
- 2021 PMT iAge® Intervention Trial by Edifice Health (NA)
- A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Manganese Chloride In Plastic Container CI brief — competitive landscape report
- Manganese Chloride In Plastic Container updates RSS · CI watch RSS
- Pfizer portfolio CI